Allergy, Asthma and Immunology Meeting
Highlights from the annual meeting of the American Academy of Allergy, Asthma and Immunology, San Antonio, February 22-26, 2013
By Nathan Seppa, 17:11 PM February 26, 2013
Promising treatment for years-long hives
People with hives that recur for years and even decades might get relief from an allergy drug. Called omalizumab and marketed as Xolair, the drug inhibits the rogue antibody immunoglobulin E, which brings on persistent, intense itching and body-covering hives in some people. Scientists randomly assigned 323 patients with chronic hives, also called urticaria, to get three shots of the medicine spaced four weeks apart. One-quarter of them got a placeb...
Source URL: https://www.sciencenews.org/article/allergy-asthma-and-immunology-meeting?mode=magazine&context=4548